| Its founder Prof. Mustafa Nevzat Pisak played an important role in establishing contemporary pharmacy in Turkey, in changing the academic pharmacy program to one fashioned on Western methods, and in the development of Turkish Pharmaceutical Industry.
His "Laboratory" is one of the first manufacturers of injectable ampoules in Turkey. With its 8 employees, the laboratory moved to another district, Divanyolu, and then to Nuruosmaniye in 1933.
In 1957 it moved to Mecidiyek鰕 and became a joint stock company. In 1984, in addition to the plant in Mecidiyek鰕, the Yenibosna facilities were established. The plant in Mecidiyek鰕, in turn, has moved to its present location at Yenibosna in 2003.
Currently, with its trained personnel of 800 and modern facilities, MN Pharmaceuticals is one of the leading manufacturers of bulk pharmaceutical chemicals and finished dosage forms.
All basic forms of pharmaceuticals, such as ampoules, vials, freeze-dried injectables, capsules, plain and coated tablets and dry powder suspensions are produced by MN Pharmaceuticals in its three separate manufacturing plants in Istanbul.
With its high-capacity injectable units and lyophilization facilities, MN Pharmaceuticals is Turkey's most experienced pharmaceutical company in parenteral drug manufacturing.
Penicillin and cephalosporin-like beta-lactam products are produced in two separate, dedicated plants.
In a separate and dedicated third plant, other groups of antibiotics, corticosteroids, cardiovascular preparations, antiinflammatory agents, gastrointestinal agents and products of other therapeutic classes are manufactured.
The products are manufactured according to "Current Good Manufacturing Practices (cGMP)" and "Current Good Laboratory Practices (cGLP)" and as a result of continuous training, education and modern technology are offered to human health care both in Turkey and in various countries abroad.
Lately, EU-GMP certificate has been given to MN Pharmaceuticals for the ampicillin sodium / sulbactam sodium for injection.
The pharmaceutical products of MN Pharmaceuticals are registered in and exported to a number of countries such as Germany, Algeria, Azerbaijan, Bulgaria, Belarus, Iraq, Republic of Kazakhstan, Republic of Lithuania, Russian Federation, Romania, Saudi Arabia, Ukraine, Georgia, Uzbekistan and Yemen.
In October 2005, MN Pharmaceuticals signed a strategic alliance agreement with one of the leading U.S. generic companies, PAR Pharmaceuticals, to develop and market generic version of injectable drugs.
Prof. Mustafa Nevzat's professional aim of always accomplishing the best and his great respect for human welfare are still the basic principles of MN Pharmaceuticals.
|
Search Product